Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
vitacig news coming R.E cbd gummies
We are currently in the process of launching our core-four, Black and Gold Label VitaCBD™ product line. This new high-end, premium VitaCBD™ CBD line will include Tincture Oil, multi-flavored CBD E-juice, delicious CBD Gummie Edibles, and a concentrated CBD Wax. Our new VitaCBD™ high end CBD product line is expected for release early next month
and will feature a new high-quality and redesigned corporate website. corporate webpage done
jsee cant see...
breaking the law is breaking the law its not tomato tomato here..
theres big differences on how it was promoted and how it was demoted in two types of recent press releases first off the positive promote was done legally with accurate information..
second the illegal demoting press release was done illegally with stock manipulation intentions and has been reported to the SEC for review by me and others...
there are very very big diffrences in casually shorting a stock as it is allowed but doing so how this article did is illegal
fourthly this article did not have any factual statements what so ever and was making false statements and was complete garbage...
https://www.sec.gov/answers/tmanipul.htm
Manipulation
Manipulation is intentional conduct designed to deceive investors by controlling or artificially affecting the market for a security. Manipulation can involve a number of techniques to affect the supply of, or demand for, a stock. They include: spreading false or misleading information about a company; improperly limiting the number of publicly-available shares; or rigging quotes, prices or trades to create a false or deceptive picture of the demand for a security. Those who engage in manipulation are subject to various civil and criminal sanctions.
please continue to report
http://seekingalpha.com/article/3948206-mcig-inc-high-smoke
Disclosure: I am/we are short MCIG.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
report this article here
https://www.sec.gov/complaint/tipscomplaint.shtml
also this seeking alpha poster has no credibility what so ever
Informer Research Informer Research?Follow(6 followers)
Hedge fund manager, long/short equity
1
Following
6
Followers
Follow
Research Driven Investment Manager
This author uses a pseudonym. See Seeking Alpha's policy on anonymous authors.
Articles
(1)
Search Author's Articles by Symbol
mCig Inc.: High On Smoke
Yesterday, 11:51 AM • MCIG61 Comments
this poster has 1 article and no credibility
YO WHERE ARE THE STICKIED POSTS......
that were there prior to 11am..
report this article here "admitted manipulation"
https://www.sec.gov/complaint/tipscomplaint.shtml
report this article
http://seekingalpha.com/article/3948206-mcig-inc-high-smoke
article quote "Disclosure: I am/we are short MCIG.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article."
&D Traders Manipulate Stock Prices With Smear Campaigns
On the other hand, S&D traders manipulate stock prices in a bear market by taking short positions and then using a smear campaign to drive down the price of the targeted stock. This is the inverse version of the "pump and dump" tactic, whereby crooks buy stock (take a long position) and issue false information that causes the target stock's price to increase.
Read more: The Short And Distort: Stock Manipulation In A Bear Market | Investopedia http://www.investopedia.com/articles/analyst/030102.asp#ixzz41m10e56h
Follow us: Investopedia on Facebook
scared its ok thanks for cheapies
bahahahaha look at this..he says hes short
Disclosure: I am/we are short MCIG.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure: This report was written under a pseudonym, Informer Research. The author of this report may have short positions in the company covered herein and stands to realize gains in the event that the price of the stock declines. Following publication, the author may transact in the securities of the company, and may be long, short, or neutral at any time. The author of this report has obtained all information contained herein from sources they believe to be accurate and reliable. The author of this report makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. All expressions of opinion are subject to change without notice, and the author does not undertake to update or supplement this report or any of the information contained herein. This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.
Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
north bound..
north bound volume was slow..
not suprised there taking advantage..buy low sell high flip em ship em forget em and rinse em.. could possibly grab a few if your up for it in these lows this month into april is good stuff...
ews out: MCIG: High On Smoke
Mar. 2, 2016 11:51 AM ET| About: mCig, Inc. (MCIG), Includes: VTCQ
Informer Research Informer Research?Follow(2 followers)
Hedge fund manager, long/short equity
Send Message
Summary
No assets, operating income, or business plan; yet a $25 million valuation.
Hidden shares, fake partnerships, and a history of other shenanigans.
Company facing cash squeeze.
MCIG: HIGH ON SMOKE
mCig Inc. (OTCQB:MCIG) is a failed e-cigarette company surviving on a cloud of smoke. mCig started as a simple e-cig brand that audaciously described itself as a "Technology Company;" now the company calls itself a "Cannabis Product Distributor," despite having no distribution assets. With no cash or gross profits to speak of, the company has been using its inflated stock as a currency to cover an unexplainably massive overhead: five of the six million dollars of overhead expense the company spent over the past 2.5 years was paid in shares! But with the stock price collapsing, capital has become scarce: last quarter, the company was too cash-strapped to even pay for its inventories. The company has no credible business plan, is riddled with all sorts of shenanigans, and at the current $25 million market capitalization, is set for a sober crash.
No Buzz
MCIG still sells its e-cigarette, the mCig 4.0, but nearly three years after its launch, the product is an obvious flop. In a 2013 interview, mCig's CEO Paul Rosenberg said that "intellectual property protection for these devices is important but secondary to being a first mover and developing brand recognition." Fast forward three years later, mCig has neither intellectual property nor brand recognition. Among the countless pages of e-cigs on amazon.com, the mCig is nowhere to be found. Maybe they sell the product directly through their website? A simple Google search for MCIG yields a barrage of websites hocking the stock, but none selling the product; telling. Google trends says that MCIG's homepage has too little traffic to even track! Searches for the mCig product correlate almost exactly with the stock price - now on a precipitous decline. The lack of web traffic is especially ironic given the company is now marketing itself as an expert in SEO and SEM services.
Revenue has grown; but the outrageously hyped growth (a) was off of a stupidly low base; (b) came with a big gross margin decline, and (c) is suspicious given accounting irregularities. While conveniently obfuscated by the pointless VitaCig (OTCPK:VTCQ) spinoff, a simple cleanup of mCig's standalone financials reveals oddities including massively negative Q4 2015 gross margins (same pattern at VitaCig - see discussion below). A theory: since MCIG aggressively reserves $0 for obsolescence and warranty reserves (see MCIG 10-q), management may have been stuffing write-offs, product returns, or warranty claims in Q4. The accounting policies haven't changed, so this year's revenues could also be overstated. Also worth noting, last quarter the company switched auditors - from a Salt Lake City firm to a China focused firm, which is odd.
shorts blowing steam engines cranking steams puffin trains leaving.. shorts already burned now there nervous...
this post from you has no direct links or connections to anyone try more please..
no hurry no worry.
its volatile nothing new..
company its self is very bullish and a major sign of this is pauls holding his shares thats a very good indicator of a companys future
dang 67k followers on twitter
https://twitter.com/mcigs
here we go.
reputable is credible 88% says yes .05+
http://www.barchart.com/opinions/stocks/MCIG
reputable is credible 88% buy rated @barchart
http://www.barchart.com/opinions/stocks/VTCQ
waiting..
waiting for that imminent subsidiary golden cross
Hey bubba check out all these royalty products..
https://www.vitastik.de/shop/
I'm laughing at ur post....
You've clearly been lacking negative commentary to down grade your comments to nit picking at he said
Forward looking statements in a un-clerical message with broad goals and objectives it's been noted over and over time and time again that you hate Mcig since inception the fruits are ripening bubba time to pick them fr your basket to purchase your Mcig cava vape materials and puff ur sad self with some vitamins that I'll mak you calm and relaxed about your Mcig depression...
Bubba its also Been noted you struggle to adapt to companies changing plans and new endeavors.. Companies do not get rich without failures trials and errors including fluff press releases that at the time of publication were attempts to show the company is actively trying new things and sells and revamps products based on tons of factors...
So bubba here we are sir sitting at .012 a share down from its high but up since its low.. I'm sure you don't have enough faith just yet in vitacig to acquire some shares.. And I'm sure you won't like vitacig for awhile because it's Mcig 1 year ago in recent development so your going to hate those fluff press releases of dreams and hopes and goals Paul Rosenberg has for his subsidiary.. And it's ever changing product services portfolio..
So bubba in closing buy a few shares.. Post ur comments and smile while we and the company answer the mysteries over time that you present us with and know because you bought a small amount of shares you'll come to realize that peterbelt100 told me to buy 100 shares or so and that we all want to be right.. My grandpa never Cheered for 1 team he cheers for both so he never lost a football game.
Go vtcq!!!
woo slap those asks =)
need some volume here.
growth large investors dilution?
do we need to be worried about dilution to raise capital or these large firms diluting shares to raise capital for vitacig
thanks.
http://www.barchart.com/headlines/story/13515745/factors-moving-markets-complementary-research-on-breathe-ecig-mcig-byd-and-theratechnologies
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Breathe Ecig Corp. (OTC:BVAP), mCig Inc. (OTC:MCIG), BYD Co. Ltd. (OTC:BYDDF) and Theratechnologies Inc. (OTC:THERF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from today's reports include:
On Friday, January 15, 2016, NASDAQ Composite ended at 4,488.42, down 2.74%, Dow Jones Industrial Average declined 2.39%, to finish the day at 15,988.08, and the S&P 500 closed at 1,880.33, down 2.16%.
- Breathe Ecig Corp.'s stock edged higher by 30.77% to close Friday's session at USD 0.0017. The company's shares oscillated between USD 0.0013 and USD 0.0018. The stock recorded a trading volume of 10.73 million shares, which was above its 50-day daily average volume of 8.57 million shares and much above its 52-week average volume of 2.29 million shares. Over the last three days Breathe Ecig Corp.'s shares have advanced 41.67%. However, over the last three months the stock has lost 69.09% and in the past six months the shares have shed 96.69%. On a compounded total return basis, the company has returned 21.43% in the past one week. The stock is currently trading below its 200-day moving average of USD 0.02. Further, the company is trading at a price to sales ratio of 6.99.
- mCig Inc.'s stock edged higher by 3.45% to close Friday's session at USD 0.030. The company's shares oscillated between USD 0.029 and USD 0.032. The stock recorded a trading volume of 0.63 million shares, which was below its 50-day daily average volume of 1.57 million shares and its 52-week average volume of 1.24 million shares. Over the last three days mCig Inc.'s shares have declined by 23.08% and in the past one week the stock has moved down 26.83%. However, over the last three months the stock has gained 27.66%; while in the past six months the shares have shed 43.45%. On a compounded total return basis, the company has returned 57.89% in the past one month. The company is trading at a price to sales ratio of 5.51 and at a price to book ratio of 29.00.
- BYD Co. Ltd.'s stock edged lower by 6.00% to close Friday's session at USD 4.53. The company's shares oscillated between USD 4.45 and USD 4.53. The stock recorded a trading volume of 0.20 million shares, which was below its 50-day daily average volume of 6.97 million shares but above its 52-week average volume of 0.11 million shares. Over the last three days BYD Co. Ltd.'s shares have declined by 5.23% and in the past one week the stock has moved down 6.31%. Furthermore, over the last three months the stock has lost 26.58% and in the past six months the shares have shed 1.37%. The stock is trading at a price to book ratio of 2.75, which compares to its historical PB ratio of 2.37. Additionally, the stock is trading at a price to cash flow ratio of 5.08 and at a price to sales ratio of 0.43.
- Theratechnologies Inc.'s stock edged lower by 8.33% to close Friday's session at USD 0.99. The company's shares oscillated between USD 0.99 and USD 1.06. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.10 million shares and slightly below its 52-week average volume of 0.04 million shares. Over the last three days Theratechnologies Inc.'s shares have declined by 8.70% and in the past one week the stock has moved down 12.78%. Furthermore, over the last three months the stock has lost 30.65% and in the past six months the shares have shed 44.64%. The stock is trading at a price to book ratio of 4.89, compared to its historical PB ratio of 2.87. Additionally, the stock is trading at a price to cash flow ratio of 31.56 and price to sales ratio of 3.96.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
http://www.accesswire.com/img.ashx?id=435741
Copyright 2016 ACCESSWIRE
http://www.barchart.com/headlines/story/13515745/factors-moving-markets-complementary-research-on-breathe-ecig-mcig-byd-and-theratechnologies
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Breathe Ecig Corp. (OTC:BVAP), mCig Inc. (OTC:MCIG), BYD Co. Ltd. (OTC:BYDDF) and Theratechnologies Inc. (OTC:THERF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from today's reports include:
On Friday, January 15, 2016, NASDAQ Composite ended at 4,488.42, down 2.74%, Dow Jones Industrial Average declined 2.39%, to finish the day at 15,988.08, and the S&P 500 closed at 1,880.33, down 2.16%.
- Breathe Ecig Corp.'s stock edged higher by 30.77% to close Friday's session at USD 0.0017. The company's shares oscillated between USD 0.0013 and USD 0.0018. The stock recorded a trading volume of 10.73 million shares, which was above its 50-day daily average volume of 8.57 million shares and much above its 52-week average volume of 2.29 million shares. Over the last three days Breathe Ecig Corp.'s shares have advanced 41.67%. However, over the last three months the stock has lost 69.09% and in the past six months the shares have shed 96.69%. On a compounded total return basis, the company has returned 21.43% in the past one week. The stock is currently trading below its 200-day moving average of USD 0.02. Further, the company is trading at a price to sales ratio of 6.99.
- mCig Inc.'s stock edged higher by 3.45% to close Friday's session at USD 0.030. The company's shares oscillated between USD 0.029 and USD 0.032. The stock recorded a trading volume of 0.63 million shares, which was below its 50-day daily average volume of 1.57 million shares and its 52-week average volume of 1.24 million shares. Over the last three days mCig Inc.'s shares have declined by 23.08% and in the past one week the stock has moved down 26.83%. However, over the last three months the stock has gained 27.66%; while in the past six months the shares have shed 43.45%. On a compounded total return basis, the company has returned 57.89% in the past one month. The company is trading at a price to sales ratio of 5.51 and at a price to book ratio of 29.00.
- BYD Co. Ltd.'s stock edged lower by 6.00% to close Friday's session at USD 4.53. The company's shares oscillated between USD 4.45 and USD 4.53. The stock recorded a trading volume of 0.20 million shares, which was below its 50-day daily average volume of 6.97 million shares but above its 52-week average volume of 0.11 million shares. Over the last three days BYD Co. Ltd.'s shares have declined by 5.23% and in the past one week the stock has moved down 6.31%. Furthermore, over the last three months the stock has lost 26.58% and in the past six months the shares have shed 1.37%. The stock is trading at a price to book ratio of 2.75, which compares to its historical PB ratio of 2.37. Additionally, the stock is trading at a price to cash flow ratio of 5.08 and at a price to sales ratio of 0.43.
- Theratechnologies Inc.'s stock edged lower by 8.33% to close Friday's session at USD 0.99. The company's shares oscillated between USD 0.99 and USD 1.06. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.10 million shares and slightly below its 52-week average volume of 0.04 million shares. Over the last three days Theratechnologies Inc.'s shares have declined by 8.70% and in the past one week the stock has moved down 12.78%. Furthermore, over the last three months the stock has lost 30.65% and in the past six months the shares have shed 44.64%. The stock is trading at a price to book ratio of 4.89, compared to its historical PB ratio of 2.87. Additionally, the stock is trading at a price to cash flow ratio of 31.56 and price to sales ratio of 3.96.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
http://www.accesswire.com/img.ashx?id=435741
Copyright 2016 ACCESSWIRE
yup just fluff...
infact its really good fluff the fluff is so good you take a puff nuff said.go VITACIG
sent a inquiry asking
mcigpod transportation question?
since growing or legalization of pot isn't legal in all states is it even legal to transport mcig pods via trucks through illegal states?
thanks..
NEWS!!! 13 2016!!!
Jan13
08:00 AM MCIG
VTCQ VitaCig Executes Landmark Royalty Agreement, Signs Lucrative Distribution Agreement for Our VitaCBD Product Line With Vitastik EU Partner
VitaCig Executes Landmark Royalty Agreement, Signs Lucrative Distribution Agreement for Our VitaCBD Product Line With Vitastik EU Partner
BEVERLY HILLS, CA--(Marketwired - Jan 13, 2016) - VitaCig, Inc. (OTC PINK: VTCQ), a technology company that is harnessing mobile vaporization technology for medical delivery applications as well as a leader in the development, marketing, and sale of ultra-pure CBD Oil tinctures, Edibles, and E-Liquids is pleased to announce it has closed on a lucrative royalty agreement and CBD product distribution, agreement with their European Vitastik Partner, Vapomins Vertriebsgesellschaft mbH.
Following several months of negotiations, VitaCig U.S., and EU Vitastik Partner, has reached an historic agreement that will entitle VitaCig U.S., to significant royalty payments of up to 25% of all product sales. This agreement will include territories and partners throughout Europe, including UK, Austria, Switzerland, Spain, Italy, covering a population of 745 million people. Spear headed, and managed by Vitastik EU CEO, Johannes Luis. According to this agreement, all product orders from Vitastik EU and their partners will go through a special EU VitaCig account. The term of this agreement runs effective January 1st 2016 - December 21st 2019. Thereafter, the agreement shall be renewed for an additional one-year-term, upon consent of both parties.
In addition to royalty payments, Vitastik EU will also take an active role in supporting our highly anticipated VitaCig product line relaunch, expected by March 1st, for the U.S. market. Not limited to, a fully mobile responsive, website design, a T.V. commercial, SEO, and Google analytics. This will well position us to experience unprecedented sales growth for 2016 and beyond.
VitaStik EU CEO Johannes Luis Schmid comments, "This strategic partnering agreement between US and EU is a huge milestone for both companies. There is strength in numbers. Our goal together, is to unite the brand, and build an empire. Dominate the disposable e-cig space. My team and I have built a solid foundation in 2015. We continue to experience record revenue growth monthly. Our re-order rate of 45%, is at an all-time high. We project to record $3.5m - $4m in revenues by year end. I look forward to contribute what has been working for us, and infuse into the U.S. market. I look forward to many years working together."
VitaCig CEO Paul Rosenberg adds, "This royalty agreement demonstrates the dynamism and value of our VitaCig brand. There is truly no other product like it on the market, and continues to see tremendous success abroad. The EU Partner agreement is part of a comprehensive effort by the company to lock-in international distribution and royalty agreements. Our vision and strategy for VitaCig is simple and clear. Dominate both the e-cig disposable, and CBD markets, on a global scale. I want to again, thank our shareholders for their patience as we continue the aggressive pursuit in reorganizing and relaunching our company and brand. I promised that shareholder value would be my top priority, and I hope this royalty agreement demonstrates the company's commitment toward that end. Due in part to the transaction with Vitastik EU, we anticipate record revenues and record adjusted profit for full-year 2016."
We are also pleased to announce, the signing of an extensive Distribution Agreement with Vitastik EU, to distribute VitaCig and mCig, Inc. (OTCQB: MCIG), whole host of ultra-pure, quality, CBD products (vitacbd.com), to their established customer and follower base, via e-commerce. This agreement also extends to all Vitastik EU partners, including partners in UK, Spain, Switzerland, and Austria. The CBD industry in Europe is seeing tremendous growth as consumers and media reports continue to highlight CBD's medical potential. Both parties anticipate, the initial product order, to be no less than $200k.
"This is an important day for the company and for our shareholders, as this distribution agreement will help introduce our VitaCBD(TM) brand and line of products, to our Vitastik EU Partners sizable customer and follower base, as well as the European market as a whole. The integration of our VitaCBD(TM) health products under the EU Vitastik brand will be seamless and we expect our CBD related products to be wholeheartedly embraced by EU Vitastik customers, just as they have here in the U.S. This agreement will provide a tremendous revenue opportunity for VitaCig U.S., Vitastik EU, and all their partners. This Distribution Agreement is one of several, expected to be announced over the next few months, said Paul Rosenberg, Chief Executive Officer of VitaCig.
About VitaCig, Inc.
VitaCig, Inc. (OTC PINK: VTCQ) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig(R), a nicotine-free device.
The company's products are sold online at: www.mcig.org, www.vitacbd.com, www.vitacig.org, www.chillcbdoil.com or through affiliate websites and select brick and mortar locations.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
NEWS!!! 13 2016!!!
Jan13
08:00 AM MCIG
VTCQ VitaCig Executes Landmark Royalty Agreement, Signs Lucrative Distribution Agreement for Our VitaCBD Product Line With Vitastik EU Partner
VitaCig Executes Landmark Royalty Agreement, Signs Lucrative Distribution Agreement for Our VitaCBD Product Line With Vitastik EU Partner
BEVERLY HILLS, CA--(Marketwired - Jan 13, 2016) - VitaCig, Inc. (OTC PINK: VTCQ), a technology company that is harnessing mobile vaporization technology for medical delivery applications as well as a leader in the development, marketing, and sale of ultra-pure CBD Oil tinctures, Edibles, and E-Liquids is pleased to announce it has closed on a lucrative royalty agreement and CBD product distribution, agreement with their European Vitastik Partner, Vapomins Vertriebsgesellschaft mbH.
Following several months of negotiations, VitaCig U.S., and EU Vitastik Partner, has reached an historic agreement that will entitle VitaCig U.S., to significant royalty payments of up to 25% of all product sales. This agreement will include territories and partners throughout Europe, including UK, Austria, Switzerland, Spain, Italy, covering a population of 745 million people. Spear headed, and managed by Vitastik EU CEO, Johannes Luis. According to this agreement, all product orders from Vitastik EU and their partners will go through a special EU VitaCig account. The term of this agreement runs effective January 1st 2016 - December 21st 2019. Thereafter, the agreement shall be renewed for an additional one-year-term, upon consent of both parties.
In addition to royalty payments, Vitastik EU will also take an active role in supporting our highly anticipated VitaCig product line relaunch, expected by March 1st, for the U.S. market. Not limited to, a fully mobile responsive, website design, a T.V. commercial, SEO, and Google analytics. This will well position us to experience unprecedented sales growth for 2016 and beyond.
VitaStik EU CEO Johannes Luis Schmid comments, "This strategic partnering agreement between US and EU is a huge milestone for both companies. There is strength in numbers. Our goal together, is to unite the brand, and build an empire. Dominate the disposable e-cig space. My team and I have built a solid foundation in 2015. We continue to experience record revenue growth monthly. Our re-order rate of 45%, is at an all-time high. We project to record $3.5m - $4m in revenues by year end. I look forward to contribute what has been working for us, and infuse into the U.S. market. I look forward to many years working together."
VitaCig CEO Paul Rosenberg adds, "This royalty agreement demonstrates the dynamism and value of our VitaCig brand. There is truly no other product like it on the market, and continues to see tremendous success abroad. The EU Partner agreement is part of a comprehensive effort by the company to lock-in international distribution and royalty agreements. Our vision and strategy for VitaCig is simple and clear. Dominate both the e-cig disposable, and CBD markets, on a global scale. I want to again, thank our shareholders for their patience as we continue the aggressive pursuit in reorganizing and relaunching our company and brand. I promised that shareholder value would be my top priority, and I hope this royalty agreement demonstrates the company's commitment toward that end. Due in part to the transaction with Vitastik EU, we anticipate record revenues and record adjusted profit for full-year 2016."
We are also pleased to announce, the signing of an extensive Distribution Agreement with Vitastik EU, to distribute VitaCig and mCig, Inc. (OTCQB: MCIG), whole host of ultra-pure, quality, CBD products (vitacbd.com), to their established customer and follower base, via e-commerce. This agreement also extends to all Vitastik EU partners, including partners in UK, Spain, Switzerland, and Austria. The CBD industry in Europe is seeing tremendous growth as consumers and media reports continue to highlight CBD's medical potential. Both parties anticipate, the initial product order, to be no less than $200k.
"This is an important day for the company and for our shareholders, as this distribution agreement will help introduce our VitaCBD(TM) brand and line of products, to our Vitastik EU Partners sizable customer and follower base, as well as the European market as a whole. The integration of our VitaCBD(TM) health products under the EU Vitastik brand will be seamless and we expect our CBD related products to be wholeheartedly embraced by EU Vitastik customers, just as they have here in the U.S. This agreement will provide a tremendous revenue opportunity for VitaCig U.S., Vitastik EU, and all their partners. This Distribution Agreement is one of several, expected to be announced over the next few months, said Paul Rosenberg, Chief Executive Officer of VitaCig.
About VitaCig, Inc.
VitaCig, Inc. (OTC PINK: VTCQ) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig(R), a nicotine-free device.
The company's products are sold online at: www.mcig.org, www.vitacbd.com, www.vitacig.org, www.chillcbdoil.com or through affiliate websites and select brick and mortar locations.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
long is strong gunna be smokin a bong
i know.
there are differences yes. but i based it simply off pps/revenue
xxii has 200 patents but only 13m revs with a 1.10/share
but something that should be said about vpco vs mcig is that
vpco has a huge products portfolio and mcig has 5-10 different products generating 4,8m income in my opinion that tells me mcigs marketing is way better than its competitors..in my opinion supporting a higher share value...
help me undertand.
so as a example ticker xxii had 12mln in revenue 2015 and is valued at 1.10 a share.. and is in the smoking industry
another example ticker vpco Net Income (13,852) valued at .20
mcig has Net Income (4,869)
so why is mcig valued so cheaply? why are other simular stockss fractionally slightly larger incomes valued so much higher than mcig? i just dont understand why the market hates mcig?
THANK YOU.
febuary 2016
quote from dec 17 press release
Lastly, we wanted to take this time to thank all of our customers and shareholders for their patience as we prepare to re-launch our VitaCig product line and company. This will include a new design and logo, redesigned corporate website, and highly anticipated VitaCig "Nic" nicotine line. We expect official relaunch of these products and updates to be complete in early February 2016.
Peterbelt - There's a reason why VitaStik already failed domestically and internationally. It's not that a good a product. It was a fad that has already passed.
You say it's a wonderful non-nicotine alternative to NOT smoking or vaping nicotine based juices. A "healthy" choice. First of all, everyone knows that vaping vitamins is a hoax and that there are not health benefits whatsoever because the amount of vitamins absorbed into the body is insignificant.
peterbelt100:your stating theres "ZERO" health benefits while you knowingly know that-that statement you just stated is crap there are health benefits and its small how ever as a alternative to conventional high chemical e cig products you know that we all know vitacig is healthy based on that and that vitacig's healthy brand is a firey topic among health professionals and has had very small amounts of scientific studies of wich concluded those studies showed small benefits and i believe vitacig should pay to run studies of its own to show the unidentified good results that havent been studied...
If it's such a great healthy choice, why didn't it sell?
peterbelt100:it is selling! mind you we are a micro cap stock acquiring market share and vitacig continues to push a very fast growing product line you simple seriously need to sit back relax and stop negatively representing a subsidiary of a fast growing company of wich mcig's CEO paul just took over vitacig needs 3-6 quarters to show revenue growth and brand awareness vitacig is small what do you want 30m revenue today? what proof do you seek vitacig reported revenue even after spending a good chunk on growth with partners over seas and in north america the 90+ representatives are people like you and me who have signed up and have been approved to push product sales in there country with a 20% commission base with a payment structure that eludes negative shareholder outcome while supporting commission sales representatives with reward based on patience and strong sales to sell there shares in the future of wich those sales representatives are locked on share sales...
Social media consultants want you to think it's because MCIG/VTCQ "didn't try" selling it here in the good ol USA. They only tried selling internationally. You know it failed domestically because it didn't sell the first go around.
Wake up. It FAILED domestically AND Paul/VTCQ guaranteed international failure by agreeing to a very, very bad contract with international distributors. That contract is still in effect, no? No announcement that it's been successfully changed, correct? Prolly locked in for 3-5 years, buddy. If it wasn't a bad contract to begin with, why would Paul/VTCQ find a need to "renegotiate"? LOL
One can increase revenues by selling both thc based AND nicotine based products because there's actual demand for those products.
peterbelt100: vitacig has plans on selling both of those types of products those products and related news regarding the nicotine launch wre slated for 2016.
Again, the only way VitaStik is going to sell is if it's part of a smoking cessation program. You incorporate nicotine based juices AND vitaStiks - AS A SMOKING CESSATION program. We're not talking rocket science here.
peterbelt100: as i stated i believe mcig and vitacig expecually vitacig should pay to run several scientific studies backing the vitacig labels and brand mind you vitacig is the only vita brand posting nutrition labels on its products competers arent doing so..
It wasn't long ago that Paul said he wanted nothing to do with the $35 BILLION dollar USA tobacco industry.
peterbelt100: its only 35 billion!? if mcig captures .001% of that per quarter were making 350k per quarter.. mind you paul is very aggressive about growth and he thrives on knowing theres oppertunity and market share that could be taken lets assume our sales commissions operations on a global scale were able to generate .001% of the 610billion in anual revenue thats 6,1m per quarter thats 24m a year just in tobacco sales why wouldnt paul seek every oppertunity to aggressively grow and strive as a CEO and entrepreneur http://www.statista.com/statistics/279866/value-of-global-tobacco-industry/
Social media consultants said nicotine based juices will be ready early January 2016. Where is it?
peterbelt100: early is relative its 1/6/15 theres 24 more days god forbid he release it late a few days its his company he can choose whens best mind you he has adopted a relase news only if its been done approach since his early happenings he learned from...
Where is the renegotiated contract?
peterbelt100:2016...
Where is the thc based juices?
peterbelt100:2016...
And despite what Social media consultants are trying to tell everyone, companies are actually MORE valuable when you sell MORE, not less.
peterbelt100:i seem to keep repeating paul needs time 3-6 quarters
---->>>> your very impatient
Do you really think VTCQ is worth more if it sells less? No, I didn't think so. And I'm pretty sure that noone instructed VTCQ to stop operations or sales. The lack of revenues was due to a bad product, bad management, bad sales model. Those supposed 90+ salesman aren't very good at sales, are they? One wonders if they actually have 90+ salesmen
peterbelt100: 90+ sales personnel globaly yes why do you think we hear about south korea japan south africa in the news those are sales reps on the commission based pay of 20%...
support that idea..
financial report comes out week 3
they wouldn't report it on the 15th a friday so i believe week 3 we get the financials.. id be surprised if it comes week 2.